An immune-cell therapy shrank children's brain tumors, restored neurologic function and—for one participant in a Stanford ...

Harvard Medical School researchers have taken another decisive step in their efforts to develop a gene therapy for people ...

The company, which secured $200 million from investors in a private funding deal last week, learned Tuesday of a serious side ...

An experimental vaccine teaching patients’ immune systems to identify and attack cancer cells could help women diagnosed with ...

Diamond-Blackfan anemia (DBA) is a rare, life-threatening genetic blood disorder. It impairs the bone marrow's ability to ...

Analysts did not seem very concerned by the treatment-related serious adverse event, noting that NGN-401 was well-tolerated ...

Isha Bhonde, an experienced physical therapist and advocate for holistic elder care, has been exploring how physical therapy ...

A new study has demonstrated the potential impact of psilocybin-assisted therapy on people with depression, if approved by ...

The funds will primarily support the company's Phase 1 clinical trial of its lead oncology candidate, VIPER-101, an ...

Our additional preliminary studies demonstrate that dual targeting of multiple myeloma cells and BM-CAFs by CAR-T cells is ...

After a comprehensive two-year follow-up, researchers found that MRI-guided stereotactic body radiotherapy (SBRT) for prostate cancer significantly reduced long-term side effects and improved quality ...

In the final episode, experts at UCSD and La Jolla Institute discuss current clinical trials of a cancer vaccine and future directions for neoantigen vaccines. Custom-made Cancer Therapy ...